ANEW MEDICAL, INC. Stock

Equities

Market Closed - OTC Markets Other stock markets 13:09:42 2024-06-13 EDT			5-day change	1st Jan Change
0.0003 ^USD	0.00%		0.00%	-76.92%

2023	ANEW MEDICAL, INC. entered into a definitive merger agreement to acquire Redwoods Acquisition Corp. from Redwoods Capital LLC and others for approximately $110 million in a reverse merger transaction.	CI
2022	Anew Medical, Inc Receives Notification of Issuance of Alzheimer's Gene Therapy Patent and Claims by the European Patent Organization	CI

Duration

Period

Style

ANEW MEDICAL, INC. entered into a definitive merger agreement to acquire Redwoods Acquisition Corp. from Redwoods Capital LLC and others for approximately $110 million in a reverse merger transaction.	23-05-29	CI
Anew Medical, Inc Receives Notification of Issuance of Alzheimer's Gene Therapy Patent and Claims by the European Patent Organization	22-12-26	CI
Anew Medical, Inc. Acquires Five Drug Approvals with Manufacturing in Europe	22-10-04	CI
Strategic Asset Leasing Inc. Auditor Raises 'Going Concern' Doubt	22-07-10	CI
Strategic Asset Leasing Inc. entered into a Letter of Intent to acquire Cryptocurrency Mining Data Center in New Jersey.	20-09-16	CI
Strategic Asset Leasing Inc. Appoints Jason Tucker as CEO	20-06-03	CI
Strategic Asset Leasing Inc. Announces Board Changes	20-06-03	CI
Strategic Asset Leasing Inc. will Change its Ticker to LEAS from MMTE.D	14-12-12	CI
Mammoth Energy In Talks To Divest Chilean Subsidiary	14-04-09	CI
Mammoth Energy Mulls Acquisitions	13-11-12	CI
Mammoth Energy Group, Inc. will Change its Ticker to MMTE from MMTE.D	13-09-17	CI
Mammoth Energy Group, Inc. will Change its Ticker to MMTED from MMTE	13-08-19	CI
Mammoth Energy Approached For Potential Acquisition Of Chilean Lithium Assets	12-07-17	CI
Mammoth Energy Eyes Acquisitions	12-07-17	CI

BigTime Penny Stocks: Rapid Growth in Gene Therapy Market (GNPX, LEAS;RWOD, VYGR, AVRO)	23-06-01	AQ
ANEW MEDICAL, INC. to Present at the Emerging Growth Conference on Wednesday, 01/11/23	23-01-09	PR
ANEW MEDICAL Receives Notification of Issuance of Alzheimer's Gene Therapy Patent and Claims by the European Patent Organization (EPO)	22-12-26	PR
ANEW MEDICAL, INC. Acquires World Wide License to Treat Neurodegenerative Diseases Using a Longevity Protein and Gene Therapy Programs.	22-12-07	PR
ANEW MEDICAL, INC. To Present at Investor Summit Group's Q4 Conference	22-11-07	NE